Get the Stockscreener App
3.68
1.94%
0.07
Engene Holdings Inc stock is traded at $3.68, with a volume of 31,379.
It is up +1.94% in the last 24 hours and up +4.84% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$3.61
Open:
$3.67
24h Volume:
31,379
Relative Volume:
0.34
Market Cap:
$188.07M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-0.80
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
+0.00%
1M Performance:
+4.84%
6M Performance:
-37.63%
1Y Performance:
-37.63%
1-Day Range:
$3.54
$3.80
1-Week Range:
$3.5165
$3.8881
52-Week Range:
$2.65
$11.00
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
3.68 | 184.49M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
Published on: 2025-08-16 15:22:56 - thegnnews.com
Signal strength of enGene Holdings Inc. Equity Warrant stock in tech scanners2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
How to monitor enGene Holdings Inc. Equity Warrant with trend dashboardsEntry Point & AI Driven Stock Reports - Newser
Visual analytics tools that track enGene Holdings Inc. Equity Warrant performance2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - Newser
What MACD and RSI say about enGene Holdings Inc. Equity WarrantWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
Comparing enGene Holdings Inc. Equity Warrant in custom built stock radars2025 Volume Leaders & Long-Term Capital Growth Ideas - Newser
Can machine learning forecast enGene Holdings Inc. Equity Warrant recoveryWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Volume spikes in enGene Holdings Inc. Equity Warrant stock – what they meanPortfolio Gains Summary & Community Consensus Picks - Newser
Is enGene Holdings Inc.’s ROE strong enough2025 Trading Recap & Growth-Oriented Investment Plans - thegnnews.com
enGene Holdings Inc. stock trend outlook and recovery pathTrade Risk Report & Daily Stock Trend Reports - Newser
Can enGene Holdings Inc. Equity Warrant recover in the next quarterFed Meeting & Daily Market Momentum Tracking - Newser
Forecasting enGene Holdings Inc. price range with options data2025 Top Decliners & Reliable Entry Point Alerts - Newser
How to use a screener to detect enGene Holdings Inc. breakoutsMarket Growth Review & AI Driven Price Forecasts - Newser
Applying Elliott Wave Theory to enGene Holdings Inc. Equity WarrantJuly 2025 Review & Accurate Intraday Trade Tips - Newser
Market reaction to enGene Holdings Inc.’s recent news2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
Is enGene Holdings Inc. still worth holding after the dipJuly 2025 Pullbacks & Weekly High Return Opportunities - Newser
Using portfolio simulators with enGene Holdings Inc. Equity Warrant includedDollar Strength & Real-Time Buy Signal Alerts - Newser
Does enGene Holdings Inc. stock pay reliable dividendsOptions Play & High Accuracy Trade Signal Alerts - Newser
enGene Holdings Inc. Company Revenue and Profit Trends: A Deep DiveJuly 2025 Pullbacks & Weekly High Potential Stock Alerts - Newser
How institutional ownership impacts enGene Holdings Inc. Equity Warrant stock2025 Buyback Activity & Daily Growth Stock Tips - Newser
What does recent volatility data suggest for enGene Holdings Inc.Volume Spike & Weekly Watchlist for Consistent Profits - Newser
How to integrate enGene Holdings Inc. into portfolio analysis tools2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
How to use Fibonacci retracement on enGene Holdings Inc. Equity WarrantTrade Setup Builder with Custom Alerts - Newser
Technical signs of recovery in enGene Holdings Inc. Equity Warrant [Market Rally]High Conviction Trade Alerts - Newser
How to track smart money flows in enGene Holdings Inc. Equity WarrantReliable Setup Screener with Low Risk - Newser
Is enGene Holdings Inc.’s growth already priced inTriple Digit ROI Screener - newsyoung.net
Knightscope Inc. Recovery Potential Based on Technical ToolsConfirmed Setup With Expert Accuracy Supported - 선데이타임즈
Published on: 2025-08-12 06:47:19 - Newser
Earnings visualization tools for enGene Holdings Inc.Reversal Pattern Insights with Entry Tips - Newser
Why enGene Holdings Inc. stock attracts strong analyst attentionProfitable Trading Blueprint with Entry Zones - Newser
enGene Holdings Inc. stock trend forecastGrowth Watchlist for Long Term Positioning - Newser
Live market analysis of enGene Holdings Inc. Equity WarrantValue Investing Checklist with Entry Signals - Newser
What makes enGene Holdings Inc. Equity Warrant stock price move sharplyInvestment Timing Strategy with Market Filters - Newser
How to recover losses in enGene Holdings Inc. stockMulti-Year Signal Summary and Entry Timing - Newser
Tools to assess enGene Holdings Inc. Equity Warrant’s risk profileChart Confirmation Setup with ROI Signals - Newser
Understanding enGene Holdings Inc. Equity Warrant’s price movementFree High Return Stock Focus With Safety - Newser
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Engene Holdings Inc Stock (ENGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Forbion Growth Opportunities F | 10% Owner |
Sep 30 '24 |
Buy |
6.34 |
341,332 |
2,163,362 |
2,400,791 |
| Forbion Growth Opportunities F | 10% Owner |
Sep 27 '24 |
Buy |
5.97 |
41,639 |
248,699 |
2,059,459 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 01 '24 |
Buy |
6.44 |
35,279 |
227,158 |
2,436,070 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 07 '24 |
Buy |
6.55 |
11,844 |
77,531 |
2,469,833 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 02 '24 |
Buy |
6.37 |
10,153 |
64,697 |
2,446,223 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 04 '24 |
Buy |
6.54 |
5,997 |
39,242 |
2,457,989 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 03 '24 |
Buy |
6.48 |
5,769 |
37,397 |
2,451,992 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 08 '24 |
Buy |
6.60 |
800 |
5,278 |
2,470,633 |
| Cooper Ronald Harold Wilfred | Chief Executive Officer |
Sep 27 '24 |
Buy |
5.70 |
10,000 |
57,000 |
10,000 |
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):